Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sexual Function and Wellbeing in Males Diagnosed With Rectal Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Swedish Cancer Society
Information provided by (Responsible Party):
Anna Martling, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT01216202
First received: October 4, 2010
Last updated: February 25, 2016
Last verified: February 2016

October 4, 2010
February 25, 2016
April 2010
December 2016   (final data collection date for primary outcome measure)
Sexual function [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01216202 on ClinicalTrials.gov Archive Site
Hormone levels [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Sexual Function and Wellbeing in Males Diagnosed With Rectal Cancer
Not Provided
Preoperative radiotherapy and pelvic surgery is recommended to many patients with rectal cancer. For men there are theoretical reasons to believe that the treatment may effect hormone levels, spermatogenesis, sexual function and wellbeing. To address these questions a longitudinal observational study was initiated where patients can choose to take part in one, two or three parts of the study. The three different parts are blood tests, questionnaires and semen samples.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Men with rectal cancer stadium I-III, planned for abdominal surgery with or without preoperative radiotherapy.
Rectal Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
100
December 2016
December 2016   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Males diagnosed with rectal cancer stadium I-III, planned for surgery with or without preoperative radiotherapy

Exclusion Criteria:

  • Rectal cancer stadium IV
  • Previous radiotherapy to the pelvic region
Male
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Sweden
 
NCT01216202
2009/1860-31/2
Yes
Not Provided
Not Provided
Anna Martling, Karolinska Institutet
Karolinska Institutet
Swedish Cancer Society
Not Provided
Karolinska Institutet
February 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP